Federated Investors »

Revance Therapeutics shares owned by Federated Investors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Federated Investors from 13F filings

Historical chart of Federated Investors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Federated Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Federated Investors

Quarter filed Position value Share count Share price at filing
2023-12-31 $722k 82k 8.79
2023-09-30 $445k 39k 11.47
2023-06-30 $163k 6.4k 25.31
2022-12-31 $670k 36k 18.46
2022-09-30 $2.6M 96k 26.97
2022-06-30 $1.7M 121k 13.79
2018-09-30 $2.1M 84k 24.85
2018-06-30 $2.2M 80k 27.46
2018-03-31 $1.8M 59k 30.79
2017-12-31 $1.4M 38k 35.75
2017-09-30 $1.4M 50k 27.55
2017-06-30 $528k 20k 26.40
2017-03-31 $417k 20k 20.80
2016-12-31 $414k 20k 20.70
2016-09-30 $324k 20k 16.20
2016-06-30 $272k 20k 13.60
2016-03-31 $349k 20k 17.45
2015-12-31 $683k 20k 34.15
2014-03-31 $1.6M 50k 31.51